A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Spaces That Support: Patient-Centered Design for Modern Reproductive Health
Modernization of Buildings Require Collaboration Across All Disciplines
Children's Health Announces Plans for RedBird Specialty Center in Texas
How Can Healthcare Facilities Use Efficiency to Drive Climate and Health Goals?
El Camino Health Rehabilitation Hospital Officially Tops Out